Inventor · disambiguated record
Anthony F. Purchio
Also filed as: PURCHIO ANTHONY · PURCHIO ANTHONY F
28 granted patents·4 pending applications·1,521 citations·filing 1983–2012
97Inventor score
Files withONCOGEN8XENOGEN CORP6ADVANCED TISSUE SCIENCES2ADVANCED TISSUE SCIENCES INC2BRISTOL MYERS SQUIBB CO2
Top patents by PatentIndex Score
32 records- 0195US5902741AThree-dimensional cartilage culturesADVANCED TISSUE SCIENCES INC·Filed 1995·Granted May 11, 1999·490 cites·36 claims
- 0293US5262177ARecombinant viruses encoding the human melanoma-associated antigenONCOGEN·Filed 1987·Granted Nov 16, 1993·123 cites·34 claims
- 0392US5919702AProduction of cartilage tissue using cells isolated from Wharton's jellyADVANCED TISSUE SCIENCE INC·Filed 1996·Granted Jul 6, 1999·272 cites·6 claims
- 0490US4661450AMolecular cloning of RNA using RNA ligase and synthetic oligonucleotidesMOLECULAR GENETICS RES & DEV·Filed 1983·Granted Apr 28, 1987·144 cites·39 claims
- 0585US5599788AMethod for accelerating skin wound healing with H3 proteinADVANCED TISSUE SCIENCES·Filed 1994·Granted Feb 4, 1997·45 cites·8 claims
- 0684US7056728B2Compositions and methods for use thereof in modifying the genomes of microorganismsXENOGEN CORP·Filed 2001·Granted Jun 6, 2006·13 cites·22 claims
- 0782US5597578ATGF-β protein compositions for inhibition of cell proliferationONCOGEN·Filed 1994·Granted Jan 28, 1997·65 cites·14 claims
- 0882US5444164ATGF-β induced geneBRISTOL MYERS SQUIBB CO·Filed 1992·Granted Aug 22, 1995·59 cites·4 claims
- 0980US5221620ACloning and expression of transforming growth factor β2ONCOGEN·Filed 1989·Granted Jun 22, 1993·48 cites·2 claims
- 1079US7449567B2Isolation and identification of mouse and human transcription control elements associated with cytochrome expressionXENOGEN CORP·Filed 2002·Granted Nov 11, 2008·15 cites·12 claims
- 1175US5141742AVaccines against melanomaONCOGEN·Filed 1991·Granted Aug 25, 1992·48 cites·16 claims
- 1274US7196190B2Methods and compositions for screening for angiogenesis modulating compoundsXENOGEN CORP·Filed 2000·Granted Mar 27, 2007·4 cites·12 claims
- 1374US5340925ANormal human growth regulatory receptor for TGF-βONCOGEN·Filed 1992·Granted Aug 23, 1994·36 cites·15 claims
- 1474US5304541AMethods using novel chimeric transforming growth factor-β1/β2BRISTOL MYERS SQUIBB CO·Filed 1991·Granted Apr 19, 1994·41 cites·2 claims
- 1572US8715954B2Method of producing C3A serum-free clonal cell lineTRIGLIA DENNIS·Filed 2008·Granted May 6, 2014·2 cites·7 claims
- 1671US6653105B2Clonal cells and cell lines derived from C3A cells and methods of making and using themVITAGEN INC·Filed 1998·Granted Nov 25, 2003·28 cites·13 claims
- 1766US6867348B1Methods and compositions for screening for angiogenesis modulating compoundsXENOGEN CORP·Filed 1999·Granted Mar 15, 2005·12 cites·2 claims
- 1865US6858773B2Transgenic mice comprising transcription control elements associated with mouse eosinophil peroxidase expressionXENOGEN CORP·Filed 2002·Granted Feb 22, 2005·6 cites·15 claims
- 1963US4735800AVaccines against rift valley fever virusMOLECULAR GENETICS INC·Filed 1984·Granted Apr 5, 1988·22 cites·88 claims
- 2062US5618715AOncostatin M and novel compositions having anti-neoplastic activityONCOGEN·Filed 1993·Granted Apr 8, 1997·17 cites·8 claims
- 2159US7390651B2C3A serum-free clonal cell line and methods of useVITAL THERAPIES INC·Filed 2003·Granted Jun 24, 2008·1 cites·6 claims
- 2259US2009210950A1Methods for screening for agents that affect developmentNUMIRA BIOSCIENCES INC·Filed 2009·Application pending·0 cites
- 2357US5714588AEnhancement of cellular attachment using H3 proteinADVANCED TISSUE SCIENCES·Filed 1997·Granted Feb 3, 1998·11 cites·20 claims
- 2453US7115793B2Isolation and identification of transcription control elements associated with mouse eosinophil peroxidase expressionXENOGEN CORP·Filed 2004·Granted Oct 3, 2006·0 cites·6 claims
- 2550US8467493B2Methods and compositions for imaging atherosclerotic plaquesPURCHIO ANTHONY F·Filed 2010·Granted Jun 18, 2013·2 cites·4 claims
- 2649US2012246745A1Methods for Screening for Agents that Affect DevelopmentPURCHIO ANTHONY F·Filed 2012·Application pending·0 cites
- 2742US5236905AIn vitro method of inhibition of HIV using transforming growth factor-.beta.ONCOGEN·Filed 1988·Granted Aug 17, 1993·4 cites·6 claims
- 2841US2002142986A1Nucleic acids encoding novel serine protease inhibitor proteins associated with the liver and methods of making and using themHEPATIX INC A CALIFORNIA CORP·Filed 2002·Application pending·0 cites
- 2939US6027935AGene up-regulated in regenerating liverADVANCED TISSUE SCIENCES INC·Filed 1996·Granted Feb 22, 2000·8 cites·11 claims
- 3035US5244793ATGF-β1/β2: a novel chimeric transforming growth factor-betaONCOGEN·Filed 1991·Granted Sep 14, 1993·4 cites·21 claims
- 3126US2010183212A1Methods and compositions for imaging cartilage and boneNUMIRA BIOSCIENCES INC·Filed 2010·Application pending·0 cites
- 3222US5844085ACloning and expression of simian transforming growth factor β1BRISTOL MYERS SQUIBB PHARMACEU·Filed 1992·Granted Dec 1, 1998·1 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Anthony F. Purchio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →